院内感染対策の世界市場：成長を牽引する効果的な感染対策への需要の高まり

当レポートでは、世界の院内感染対策市場について調査分析し、市場概要、市場動向、市場分析と予測、競合分析などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 市場範囲 / 分類法
• 市場の定義 / 範囲 / 制限
• 包含と除外

第3章 主要な市場動向

• 市場に影響を与える主要な動向
• 製品革新・開発動向

第4章 主な成功要因

• 製品採用・利用分析
• 主要なマーケティングおよびプロモーション戦略：メーカー別
• 規制状況
• 償還シナリオ
• 品質監視プログラム
• PESTEL分析
• ポーターの分析

第5章 市場の背景

• マクロ経済要因
  • 世界のGDP成長の見通し
  • 世界ヘルスケア業界の見通し
  • 院内感染市場概要
• 予測要因 - 関連性と影響
  • 個人衛生への関心の高まり
  • 感染症の蔓延
  • 新製品発売活動
  • 技術の進歩
  • 低侵襲手術の増加
  • 感受性のある患者と外科的処置
  • 共存感染
  • 政府からの資金と支援の増加
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会分析

第6章 COVID-19危機分析

• 2022年の市場シナリオ
• COVID-19と影響分析
  • 製品別
  • エンドユーザー別
  • 地域別

第7章 世界の院内感染対策市場（数量）の分析と予測

• 過去の市場分析
• 現在および将来の市場予測
  • 前年比成長動向分析

第8章 世界の院内感染対策市場 - 価格分析

• 地域別価格分析：製品別
• 価格の内訳
  • メーカーレベルの価格
  • 販売業者レベルの価格
• 世界の平均価格分析ベンチマーク
• 価格設定の前提

第9章 世界の院内感染対策市場の需要（金額・数量）の分析と予測

• 過去の市場分析
• 現在および将来の市場予測
  • 前年比成長動向分析分析

第10章 世界の院内感染対策市場の分析と予測：製品別

• イントロダクション / 主な調査結果
• 過去の市場と分析：製品別
• 現在および将来の市場分析と予測：製品別
  • 加熱殺菌装置
  • 低温殺菌装置
  • 放射線滅菌装置
  • 消毒装置
• 市場魅力度分析：製品別

第11章 世界の院内感染対策市場の分析と予測：エンドユーザー別

• イントロダクション/主な調査結果
• 過去の市場分析：エンドユーザー別
• 現在および将来の市場分析と予測：エンドユーザー別
  • 病院
  • 外来手術センター
  • 医療機関
  • 診断検査室
  • 診療所
• 市場魅力分析：エンドユーザー別

第12章 世界の院内感染対策市場の分析と予測：地域別

• イントロダクション
• 過去の市場と分析：地域別
• 現在および将来の市場分析と予測： 地域別
  • 北米
  • ラテンアメリカ
  • 欧州
  • 南アジア
  • 東アジア
  • オセアニア
  • 中東とアフリカ
• 市場魅力度分析：地域別

第13章 北米の院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • 米国
  • カナダ

第14章 ラテンアメリカの院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • メキシコ
  • ブラジル
  • アルゼンチン

第15章 欧州の院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • ベネルクス諸国

第16章 南アジアの院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • インド
  • インドネシア
  • マレーシア
  • タイ

第17章 東アジアの院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • 中国
  • 日本
  • 韓国

第18章 オセアニアの院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • オーストラリア
  • ニュージーランド

第19章 中東およびアフリカの院内感染対策市場の分析と予測

• イントロダクション
• 過去の市場と動向分析：市場分類別
• 現在および将来の市場分析と予測：市場分類別
  • 国別
  • 製品別
  • エンドユーザー別
• 市場魅力分析
  • 国別
  • 製品別
  • エンドユーザー別
• 主要な市場参入企業 - 強度マッピング
• 促進要因と抑制要因 - 影響分析
• 主要な市場動向
• 国レベルの分析と予測
  • GCC諸国
  • トルコ
  • 南アフリカ
  • 北アフリカ

第20章 市場構造分析

• 市場分析：企業層別
• 主要企業の市場シェア分析
• 市場プレゼンス分析
  • 企業の地域フットプリント
  • 製品フットプリント：企業別
  • チャネルフットプリント：企業別

第21章 競合分析

• 競合ダッシュボード
• 競合のベンチマーク
• 競合の詳細
  • Olympus Corporation
  • Medivators Inc.（Cantel Medical Corp.）
  • Getinge Group
  • STERIS Plc.
  • Belimed AG（Metall Zug）
  • Steelco S.P.A
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co.
  • Advanced Sterilization Products Services Inc.（Johnson & Johnson）
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc.
  • UVision360 Inc.

第22章 使用される仮定と頭字語

第23章 調査手法

List of Tables

• Table 01: Global Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 02: Global Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 03: Global Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 04: Global Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 05: North America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 06: North America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 07: North America Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 08: North America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 09: Latin America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 10: Latin America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 11: Latin America Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 12: Latin America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 13: Europe Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 14: Europe Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 15: Europe Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 16: Europe Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 17: South Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 18: South Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 19: South Asia Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 20: South Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 21: East Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 22: East Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 23: East Asia Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 24: East Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 25: Oceania Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 26: Oceania Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 27: Oceania Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 28: Oceania Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User
• Table 29: MEA Hospital Acquired Infection Control Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023-2033, by Country
• Table 30: MEA Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by Product
• Table 31: MEA Hospital Acquired Infection Control Market Volume (Units) Analysis and Forecast 2012-2032, by Product
• Table 32: MEA Hospital Acquired Infection Control Market Value (US$ Mn) Analysis and Forecast 2012-2032, by End User

List of Figures

• Figure 01: Global Hospital Acquired Infection Control Market Volume (Units), 2012 - 2022
• Figure 02: Global Hospital Acquired Infection Control Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2023-2033
• Figure 03: Hospital Acquired Infection Control, Pricing Analysis per unit (US$), in 2022
• Figure 04: Hospital Acquired Infection Control, Pricing Forecast per unit (US$), in 2032
• Figure 05: Global Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 06: Global Hospital Acquired Infection Control Market Forecast & Y-o-Y Growth, 2023-2033
• Figure 07: Global Hospital Acquired Infection Control Market Absolute $ Opportunity (US$ Mn) Analysis, 2023-2033
• Figure 08: Global Hospital Acquired Infection Control Market Value Share (%) Analysis 2022 and 2033, by Product
• Figure 09: Global Hospital Acquired Infection Control Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
• Figure 10: Global Hospital Acquired Infection Control Market Attractiveness Analysis 2023-2033, by Product
• Figure 11: Global Hospital Acquired Infection Control Market Value Share (%) Analysis 2022 and 2033, by End User
• Figure 12: Global Hospital Acquired Infection Control Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
• Figure 13: Global Hospital Acquired Infection Control Market Attractiveness Analysis 2023-2033, by End User
• Figure 14: Global Hospital Acquired Infection Control Market Value Share (%) Analysis 2022 and 2033, by Region
• Figure 15: Global Hospital Acquired Infection Control Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
• Figure 16: Global Hospital Acquired Infection Control Market Attractiveness Analysis 2023-2033, by Region
• Figure 17: North America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 18: North America Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 19: North America Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 20: North America Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 21: North America Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 22: North America Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 23: North America Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 24: North America Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 25: U.S. Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 26: Global Vs. U.S. Growth Comparison
• Figure 27: U.S. Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 28: U.S. Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 29: Canada Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 30: Global Vs. Canada. Growth Comparison
• Figure 31: Canada Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 32: Canada Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 33: Latin America Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 34: Latin America Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 35: Latin America Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 36: Latin America Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 37: Latin America Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 38: Latin America Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 39: Latin America Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 40: Latin America Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 41: Mexico Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 42: Global Vs Mexico Growth Comparison
• Figure 43: Mexico Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 44: Mexico Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 45: Brazil Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 46: Global Vs. Brazil. Growth Comparison
• Figure 47: Brazil Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 48: Brazil Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 49: Argentina Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 50: Global Vs Argentina Growth Comparison
• Figure 51: Argentina Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 52: Argentina Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 53: Europe Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 54: Europe Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 55: Europe Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 56: Europe Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 57: Europe Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 58: Europe Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 59: Europe Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 60: Europe Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 61: UK Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 62: Global Vs. UK Growth Comparison
• Figure 63: UK Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 64: UK Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 65: Germany Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 66: Global Vs. Germany Growth Comparison
• Figure 67: Germany Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 68: Germany Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 69: Italy Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 70: Global Vs. Italy Growth Comparison
• Figure 71: Italy Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 72: Italy Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 73: France Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 74: Global Vs France Growth Comparison
• Figure 75: France Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 76: France Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 77: Spain Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 78: Global Vs Spain Growth Comparison
• Figure 79: Spain Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 80: Spain Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 81: Russia Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 82: Global Vs Russia Growth Comparison
• Figure 83: Russia Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 84: Russia Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 85: BENELUX Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 86: Global Vs BENELUX Growth Comparison
• Figure 87: BENELUX Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 88: BENELUX Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 89: East Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 90: East Asia Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 91: East Asia Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 92: East Asia Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 93: East Asia Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 94: East Asia Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 95: East Asia Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 96: East Asia Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 97: China Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 98: Global Vs. China Growth Comparison
• Figure 99: China Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 100: China Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 101: Japan Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 102: Global Vs. Japan Growth Comparison
• Figure 103: Japan Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 104: Japan Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 105: South Korea Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 106: Global Vs South Korea Growth Comparison
• Figure 107: South Korea Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 108: South Korea Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 109: South Asia Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 110: South Asia Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 111: South Asia Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 112: South Asia Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 113: South Asia Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 114: South Asia Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 115: South Asia Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 116: South Asia Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 117: India Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 118: Global Vs. India Growth Comparison
• Figure 119: India Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 120: India Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 121: Indonesia Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 122: Global Vs. Indonesia Growth Comparison
• Figure 123: Indonesia Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 124: Indonesia Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 125: Malaysia Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 126: Global Vs. Malaysia Growth Comparison
• Figure 127: Malaysia Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 128: Malaysia Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 129: Thailand Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 130: Global Vs. Thailand Growth Comparison
• Figure 131: Thailand Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 132: Thailand Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 133: Oceania Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 134: Oceania Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 135: Oceania Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 136: Oceania Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 137: Oceania Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 138: Oceania Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 139: Oceania Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 140: Oceania Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 141: Australia Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 142: Global Vs. Australia Growth Comparison
• Figure 143: Australia Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 144: Australia Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 145: New Zealand Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 146: Global Vs New Zealand Growth Comparison
• Figure 147: New Zealand Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 148: New Zealand Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 149: Middle East & Africa Hospital Acquired Infection Control Market Value (US$ Mn) Analysis, 2012 - 2022
• Figure 150: Middle East & Africa Hospital Acquired Infection Control Market Value (US$ Mn) Forecast, 2023-2033
• Figure 151: Middle East & Africa Hospital Acquired Infection Control Market Value Share, by Product (2023 E)
• Figure 152: Middle East & Africa Hospital Acquired Infection Control Market Value Share, by End User (2023 E)
• Figure 153: Middle East & Africa Hospital Acquired Infection Control Market Value Share, by Country (2023 E)
• Figure 154: Middle East & Africa Hospital Acquired Infection Control Market Attractiveness Analysis by Product, 2023-2033
• Figure 155: Middle East & Africa Hospital Acquired Infection Control Market Attractiveness Analysis by End User, 2023-2033
• Figure 156: Middle East & Africa Hospital Acquired Infection Control Market Attractiveness Analysis by Country, 2023-2033
• Figure 157: GCC Countries Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 158: Global Vs GCC Countries Growth Comparison
• Figure 159: GCC Countries Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 160: GCC Countries Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 161: Turkey Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 162: Global Vs. Turkey Growth Comparison
• Figure 163: Turkey Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 164: Turkey Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 165: South Africa Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 166: Global Vs. South Africa Growth Comparison
• Figure 167: South Africa Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 168: South Africa Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033
• Figure 169: North Africa Hospital Acquired Infection Control Market Value Proportion Analysis, 2022
• Figure 170: Global Vs North Africa Growth Comparison
• Figure 171: North Africa Hospital Acquired Infection Control Market Share Analysis (%) by Product, 2022 & 2033
• Figure 172: North Africa Hospital Acquired Infection Control Market Share Analysis (%) by End User, 2022 & 2033

Hospital Acquired Infection Control Market: Scope of Report

The latest publication by Persistence Market Research on the hospital acquired infection control market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for the hospital acquired infection control products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the hospital acquired infection control market. Shareholders in the hospital acquired infection control market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the hospital acquired infection control market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the hospital acquired infection control market offers information divided into three important segments - product, end-user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Heat Sterilization Equipment

Moist Heat Sterilization Equipment

Dry Heat Sterilization Equipment

Low-Temperature Sterilization Equipment

Radiation Sterilization Equipment

Disinfection Equipment

Disinfector

Washer Disinfector

Flusher Disinfector

Endoscopic Reprocessor Systems

Single Basin Endoscopic Reprocessor Systems

Dual Basin Endoscopic Reprocessor Systems

Disinfectants

End User

Hospitals

Ambulatory Surgical Centres

Medical Institutions

Diagnostic Laboratories

Clinics

Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for hospital acquired infection control over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the hospital acquired infection control market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the hospital acquired infection control market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the hospital acquired infection control market are more accurate and reliable.

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Key Marketing & Promotion Strategies, By Manufacturers
• 4.3. Regulatory Landscape
• 4.4. Reimbursement Scenario.
• 4.5. Quality Monitoring Programs
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis.

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Hospital Acquired Infection Market Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising Focus on Personal Hygiene
  • 5.2.2. Increasing Prevalence of Infectious Diseases
  • 5.2.3. New Product Launch Activities
  • 5.2.4. Technological Advancements
  • 5.2.5. Increasing Minimally Invasive Procedures
  • 5.2.6. Susceptible Patients and Surgical Procedures
  • 5.2.7. Co-Existing Infections
  • 5.2.8. Increased Funding and Support from the Government
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. 2022 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Region

7. Global Hospital Acquired Infection Control Market Demand (in Volume) Analysis 2012-2022 and Forecast, 2023-2033

• 7.1. Historical Market (Volume) Analysis, 2012-2022
• 7.2. Current and Future Market (Volume) Projections, 2023-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Hospital Acquired Infection Control Market - Pricing Analysis

• 8.1. Regional Pricing Analysis, By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Hospital Acquired Infection Control Market Demand (in Value or Size in US$ Mn) Analysis 2012-2022 and Forecast, 2023-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2012-2022
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2012-2022
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2023-2033
  • 10.3.1. Heat Sterilization Equipment
    • 10.3.1.1. Moist Heat Sterilization Equipment
    • 10.3.1.2. Dry Heat Sterilization Equipment
  • 10.3.2. Low Temperature Sterilization Equipment
  • 10.3.3. Radiation Sterilization Equipment
  • 10.3.4. Disinfection Equipment
    • 10.3.4.1. Disinfector
      • 10.3.4.1.1. Washer Disinfector
      • 10.3.4.1.2. Flusher Disinfector
    • 10.3.4.2. Endoscopic Reprocessor Systems
      • 10.3.4.2.1. Single Basin Endoscopic Reprocessor Systems
      • 10.3.4.2.2. Dual Basin Endoscopic Reprocessor Systems
    • 10.3.4.3. Disinfectants
• 10.4. Market Attractiveness Analysis, By Product

11. Global Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033, By End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012-2022
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2023-2033
  • 11.3.1. Hospitals
  • 11.3.2. Ambulatory Surgical Centers
  • 11.3.3. Medical Institutions
  • 11.3.4. Diagnostic Laboratories
  • 11.3.5. Clinics
• 11.4. Market Attractiveness Analysis, By End User

12. Global Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Region, 2012-2022
• 12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2023-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. South Asia
  • 12.3.5. East Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa
• 12.4. Market Attractiveness Analysis, By Region

13. North America Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By End User
• 13.5. Key Market Participants - Intensity Mapping
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Market Trends
• 13.8. Country-Level Analysis & Forecast
  • 13.8.1. U.S. Hospital Acquired Infection Control Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By End User
  • 13.8.2. Canada Hospital Acquired Infection Control Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By End User

14. Latin America Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Product
  • 14.3.3. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By End User
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Market Trends
• 14.8. Country-Level Analysis & Forecast
  • 14.8.1. Mexico Hospital Acquired Infection Control Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By End User
  • 14.8.2. Brazil Surgical Imaging Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By End User
  • 14.8.3. Argentina Hospital Acquired Infection Control Market
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By End User

15. Europe Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
  • 15.3.1. By Country
    • 15.3.1.1. U.K.
    • 15.3.1.2. Germany
    • 15.3.1.3. Italy
    • 15.3.1.4. France
    • 15.3.1.5. Spain
    • 15.3.1.6. Russia
    • 15.3.1.7. BENELUX
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Product
  • 15.3.3. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By End User
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Market Trends
• 15.8. Country-Level Analysis & Forecast
  • 15.8.1. U.K. Hospital Acquired Infection Control Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By End User
  • 15.8.2. Germany Hospital Acquired Infection Control Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By End User
  • 15.8.3. Italy Hospital Acquired Infection Control Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By End User
  • 15.8.4. France Hospital Acquired Infection Control Market
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By End User
  • 15.8.5. Spain Hospital Acquired Infection Control Market
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Product
      • 15.8.5.2.2. By End User
  • 15.8.6. Russia Hospital Acquired Infection Control Market
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Product
      • 15.8.6.2.2. By End User
  • 15.8.7. BENULUX Hospital Acquired Infection Control Market
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Product
      • 15.8.7.2.2. By End User

16. South Asia Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By End User
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Market Trends
• 16.8. Country-Level Analysis & Forecast
  • 16.8.1. India Hospital Acquired Infection Control Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By End User
  • 16.8.2. Indonesia Hospital Acquired Infection Control Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By End User
  • 16.8.3. Malaysia Hospital Acquired Infection Control Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By End User
  • 16.8.4. Thailand Hospital Acquired Infection Control Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By End User

17. East Asia Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Market Trends
• 17.8. Country-Level Analysis & Forecast
  • 17.8.1. China Hospital Acquired Infection Control Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By End User
  • 17.8.2. Japan Hospital Acquired Infection Control Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By End User
  • 17.8.3. South Korea Hospital Acquired Infection Control Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By End User

18. Oceania Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product
  • 18.3.3. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By End User
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Market Trends
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Hospital Acquired Infection Control Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By End User
  • 18.8.2. New Zealand Hospital Acquired Infection Control Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Hospital Acquired Infection Control Market Analysis 2012-2022 and Forecast 2023-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2012-2022
• 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkey
    • 19.3.1.3. South Africa
    • 19.3.1.4. North Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Product
  • 19.3.3. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By End User
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Market Trends
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Hospital Acquired Infection Control Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By End User
  • 19.8.2. Turkey Hospital Acquired Infection Control Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By End User
  • 19.8.3. South Africa Hospital Acquired Infection Control Market
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Product
      • 19.8.3.2.2. By End User
  • 19.8.4. North Africa Hospital Acquired Infection Control Market
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Product
      • 19.8.4.2.2. By End User

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis
  • 20.3.1. Regional footprint of Players
  • 20.3.2. Product foot print by Players
  • 20.3.3. Channel Foot Print by Players

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Olympus Corporation
    • 21.3.1.1. Company Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Sales Footprint
    • 21.3.1.4. Key Financials
    • 21.3.1.5. SWOT Analysis
    • 21.3.1.6. Key Developments
    • 21.3.1.7. Strategy Overview
      • 21.3.1.7.1. Marketing Strategy
      • 21.3.1.7.2. Product Strategy
      • 21.3.1.7.3. Channel Strategy
  • 21.3.2. Medivators Inc. (Cantel Medical Corp.)
    • 21.3.2.1. Company Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Sales Footprint
    • 21.3.2.4. Key Financials
    • 21.3.2.5. SWOT Analysis
    • 21.3.2.6. Key Developments
    • 21.3.2.7. Strategy Overview
      • 21.3.2.7.1. Marketing Strategy
      • 21.3.2.7.2. Product Strategy
      • 21.3.2.7.3. Channel Strategy
  • 21.3.3. Getinge Group
    • 21.3.3.1. Company Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Sales Footprint
    • 21.3.3.4. Key Financials
    • 21.3.3.5. SWOT Analysis
    • 21.3.3.6. Key Developments
    • 21.3.3.7. Strategy Overview
      • 21.3.3.7.1. Marketing Strategy
      • 21.3.3.7.2. Product Strategy
      • 21.3.3.7.3. Channel Strategy
  • 21.3.4. STERIS Plc.
    • 21.3.4.1. Company Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Sales Footprint
    • 21.3.4.4. Key Financials
    • 21.3.4.5. SWOT Analysis
    • 21.3.4.6. Key Developments
    • 21.3.4.7. Strategy Overview
      • 21.3.4.7.1. Marketing Strategy
      • 21.3.4.7.2. Product Strategy
      • 21.3.4.7.3. Channel Strategy
  • 21.3.5. Belimed AG (Metall Zug)
    • 21.3.5.1. Company Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Sales Footprint
    • 21.3.5.4. Key Financials
    • 21.3.5.5. SWOT Analysis
    • 21.3.5.6. Key Developments
    • 21.3.5.7. Strategy Overview
      • 21.3.5.7.1. Marketing Strategy
      • 21.3.5.7.2. Product Strategy
      • 21.3.5.7.3. Channel Strategy
  • 21.3.6. Steelco S.P.A
    • 21.3.6.1. Company Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Sales Footprint
    • 21.3.6.4. Key Financials
    • 21.3.6.5. SWOT Analysis
    • 21.3.6.6. Key Developments
    • 21.3.6.7. Strategy Overview
      • 21.3.6.7.1. Marketing Strategy
      • 21.3.6.7.2. Product Strategy
      • 21.3.6.7.3. Channel Strategy
  • 21.3.7. Pfizer Inc.
    • 21.3.7.1. Company Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Sales Footprint
    • 21.3.7.4. Key Financials
    • 21.3.7.5. SWOT Analysis
    • 21.3.7.6. Key Developments
    • 21.3.7.7. Strategy Overview
      • 21.3.7.7.1. Marketing Strategy
      • 21.3.7.7.2. Product Strategy
      • 21.3.7.7.3. Channel Strategy
  • 21.3.8. F. Hoffmann-La Roche Ltd
    • 21.3.8.1. Company Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Sales Footprint
    • 21.3.8.4. Key Financials
    • 21.3.8.5. SWOT Analysis
    • 21.3.8.6. Key Developments
    • 21.3.8.7. Strategy Overview
      • 21.3.8.7.1. Marketing Strategy
      • 21.3.8.7.2. Product Strategy
      • 21.3.8.7.3. Channel Strategy
  • 21.3.9. Merck & Co.
    • 21.3.9.1. Company Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Sales Footprint
    • 21.3.9.4. Key Financials
    • 21.3.9.5. SWOT Analysis
    • 21.3.9.6. Key Developments
    • 21.3.9.7. Strategy Overview
      • 21.3.9.7.1. Marketing Strategy
      • 21.3.9.7.2. Product Strategy
      • 21.3.9.7.3. Channel Strategy
  • 21.3.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
    • 21.3.10.1. Company Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Sales Footprint
    • 21.3.10.4. Key Financials
    • 21.3.10.5. SWOT Analysis
    • 21.3.10.6. Key Developments
    • 21.3.10.7. Strategy Overview
      • 21.3.10.7.1. Marketing Strategy
      • 21.3.10.7.2. Product Strategy
      • 21.3.10.7.3. Channel Strategy
  • 21.3.11. Abbott Laboratories
    • 21.3.11.1. Company Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Sales Footprint
    • 21.3.11.4. Key Financials
    • 21.3.11.5. SWOT Analysis
    • 21.3.11.6. Key Developments
    • 21.3.11.7. Strategy Overview
      • 21.3.11.7.1. Marketing Strategy
      • 21.3.11.7.2. Product Strategy
      • 21.3.11.7.3. Channel Strategy
  • 21.3.12. Bayer AG
    • 21.3.12.1. Company Overview
    • 21.3.12.2. Product Portfolio
    • 21.3.12.3. Sales Footprint
    • 21.3.12.4. Key Financials
    • 21.3.12.5. SWOT Analysis
    • 21.3.12.6. Key Developments
    • 21.3.12.7. Strategy Overview
      • 21.3.12.7.1. Marketing Strategy
      • 21.3.12.7.2. Product Strategy
      • 21.3.12.7.3. Channel Strategy
  • 21.3.13. Alere Inc.
    • 21.3.13.1. Company Overview
    • 21.3.13.2. Product Portfolio
    • 21.3.13.3. Sales Footprint
    • 21.3.13.4. Key Financials
    • 21.3.13.5. SWOT Analysis
    • 21.3.13.6. Key Developments
    • 21.3.13.7. Strategy Overview
      • 21.3.13.7.1. Marketing Strategy
      • 21.3.13.7.2. Product Strategy
      • 21.3.13.7.3. Channel Strategy
  • 21.3.14. The 3M Company
    • 21.3.14.1. Company Overview
    • 21.3.14.2. Product Portfolio
    • 21.3.14.3. Sales Footprint
    • 21.3.14.4. Key Financials
    • 21.3.14.5. SWOT Analysis
    • 21.3.14.6. Key Developments
    • 21.3.14.7. Strategy Overview
      • 21.3.14.7.1. Marketing Strategy
      • 21.3.14.7.2. Product Strategy
      • 21.3.14.7.3. Channel Strategy
  • 21.3.15. Cepheid Inc.
    • 21.3.15.1. Company Overview
    • 21.3.15.2. Product Portfolio
    • 21.3.15.3. Sales Footprint
    • 21.3.15.4. Key Financials
    • 21.3.15.5. SWOT Analysis
    • 21.3.15.6. Key Developments
    • 21.3.15.7. Strategy Overview
      • 21.3.15.7.1. Marketing Strategy
      • 21.3.15.7.2. Product Strategy
      • 21.3.15.7.3. Channel Strategy
  • 21.3.16. UVision360 Inc.
    • 21.3.16.1. Company Overview
    • 21.3.16.2. Product Portfolio
    • 21.3.16.3. Sales Footprint
    • 21.3.16.4. Key Financials
    • 21.3.16.5. SWOT Analysis
    • 21.3.16.6. Key Developments
    • 21.3.16.7. Strategy Overview
      • 21.3.16.7.1. Marketing Strategy
      • 21.3.16.7.2. Product Strategy
      • 21.3.16.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology